• 沒有找到結果。

期刊論文

Bertram, Elana A., How to Keep Your Invention Patentable While It is Stored in the Cloud: A Guide for Small Inventors, 21 FED.CIRCUIT B.J.

389 (2011).

Case, Jennifer L., How the America Invents Act Hurts American Inven-tors and Weakens Incentives to Innovate, 82 UMKCL.REV. 29 (2013).

Chen, Quincy (Ping-Hsun), Destroying a Pharmaceutical Patent for Sav-ing Lives? A Case Study of Sanofi-Synthelabo v. Apotex, Inc., 21 ALB. L.J.SCI.&TECH. 125 (2011).

Correa, Carlos M., The GATT Agreement on Trade-Related Aspects of In-tellectual Property Rights: New Standards for Patent Protection, 16(8) E.I.P.R. 327 (1994).

Fernandes, Siddharth, A Realistic Analysis of§271(g) and the ITC: Aca-demic Hypotheses Aside,§271(g) does not Violate the Paris Convention or TRIPS Because its Affirmative Defenses do not Apply to§337 Actions Before the ITC, 17 FED.CIRCUIT B.J. 473 (2008).

Foster, George K., Comment, Opposing Forces in a Revolution in Inter-national Patent Protection: The U.S. and India in the Uruguay Round and Its Aftermath, 3 UCLAJ.INTL L.&FOREIGN AFF. 283 (1998).

Frisvold, George & Day-Rubenstein, Kelly, Bioprospecting and Biodi-versity Conservation: What Happens When Discoveries Are Made?, 50 ARIZ.L.REV. 545 (2008).

Halasz, Ty, Comments, The Game of the Name: Shortcomings in the Du-al-Agency Review of Drug Trademarks and a Remedial Cure, 64 ADMIN. L.REV. 235 (2012).

Hason, Averie K. & Shimotake, Jean E., Recent Developments in Patent Rights for Pharmaceuticals in China and India, 18 PACE INTL L.REV. 303 (2006).

Heo, Jae Ho et al., Development of New Efficient Synthetic Methods for Docetaxel, 30(1) BULL.KOREAN CHEM.SOC. 25 (2009).

Hicks, Laurinda L. & Holbein, James R., Convergence of National Intel-lectual Property Norms in International Trading Agreements, 12 AM.U.

J.INTL L.&POLY 769 (1997).

Kongolo, Tshimanga, Morocco’s Patent System and its International Connection, 42 IDEA 181 (2002).

Lesser, William, Measuring Intellectual Property ‘Strength’ and Effects:

An Assessment of Patent Scoring Systems and Causality, 4 J.BUS.E N-TREPRENEURSHIP &L. 345 (2011).

Li, Anne Elise Herold, Note, Is the Federal Circuit Affecting U.S. Trea-ties? The ITC, §271(g), GATT/TRIPS & the Kinik Decision, 16 F ORD-HAM INTELL.PROP.MEDIA &ENT.L.J. 601 (2006).

Liu, Benjamin Piwei, Chinese Patents as Copyrights, 34 CAMPBELL L.

REV. 685 (2012).

Matthews, Duncan & Wilson, Caroline, Pharmaceutical Regulation in the Single European Market, 17 MED.&L. 401 (1998).

Mercurio, Bryan & Tyagi, Mitali, Treaty Interpretation in WTO Dispute Settlement: The Outstanding Question of the Legality of Local Working Requirements, 19 MINN.J.INTL L. 275 (2010).

Metzler, Renee E., Comment, Not All Grace Periods are Created Equal:

Building a Grace Period from the Ground Up, 13 MARQ.INTELL.PROP. L.REV. 371 (2009).

Mueller, Janice M., Biotechnology Patenting in India: Will Bio-Generics Lead a “Sunrise Industry” to Bio-Innovation?, 76 UMKCL.REV. 437 (2007).

Mueller, Janice M., The Tiger Awakens: The Tumultuous Transformation of India’s Patent System and the Rise of Indian Pharmaceutical Innova-tion, 68 U.PITT.L.REV. 491 (2007).

Sell, Susan K., Industry Strategies for Intellectual Property and Trade:

The Quest for TRIPS, and Post-TRIPS Strategies, 10 CARDOZO J.INTL

&COMP.L. 79 (2002).

Shanker, Daya, Argentina-US Mutually Agreed Solution, Economic Cri-sis in Argentina and Failure of the WTO Dispute Settlement System, 44 IDEA 565 (2004).

Skinner, Jonathan, Overcoming Babel’s Curse: Adapting the Doctrine of Foreign Equivalents, 93 J.PAT.&TRADEMARK OFF.SOCY 57 (2011).

Sorell, Louis S., A Comparative Analysis of Selected Aspects of Patent Law in China and the United States, 11 PAC. RIM L. & POLY J. 319 (2002).

Straus, Joseph, A Marriage of Convenience: World Economy and Intel-lectual Property from 1990 to 2012, 40 AIPLAQ.J. 633 (2012).

Sun, Andy Y., From Pirate King to Jungle King: Transformation of Tai-wan’s Intellectual Property Protection, 9 FORDHAM INTELL.PROP.M E-DIA &ENT.L.J. 67 (1998).

Trias de Bes, Miguel Vidal-Quadras, Process Patents on New Products and Reversal of the Burden of Proof: Factors Contributing to the Inter-pretation of Its Scope, 24(5) E.I.P.R. 237 (2002).

Unni, Venugopal K., Indian Patent Law and TRIPS: Redrawing the Flexibility Framework in the Context of Public Policy and Health, 25 PAC.MCGEORGE GLOBAL BUS.&DEV.L.J. 323 (2012).

World Health Organization [WHO], Proposed INN List 70 International Nonproprietary Names for Pharmaceutical Substances, 7(4) WHO DRUG

INFORMATION 203 (1993).

WHO, Proposed International Nonproprietary Names (Proposed INNs):

List 63, 4(2) WHO DRUG INFORMATION 1 (1990).

WHO, Amendments to Previous Lists, 6(4) WHO DRUG INFORMATION 15 (1992).

Zanzig, Laura, Comment, The Perfect Pairing: Protecting U.S. Geo-graphical Indications with a Sino-American Wine Registry, 88 WASH. L.REV. 723 (2013).

網頁文獻

Agreement relating to Community Patents art. 35 (done at Luxembourg on 15 Dec. 15. 1989), 89/695/EEC, http://eur-lex.europa.eu/LexUriServ/

LexUriServ.do?uri=CELEX:41989A0695(01):EN:HTML (last visited:

2015.05.14).

AMA, How to Apply for a Name─Obtain a CAS Registry Name and Number, http://www.ama-assn.org/ama/pub/physician-resources/medical-science/united-states-adopted-names-council/how-to-apply-for-usan.page?

(last visited: 2013.12.03).

 American Chemical Society, https://www.cas.org/content/chemical-substances/faqs (last visited: 2013.11.30).

 American Medical Association [AMA], How to Apply for a Name─When to Apply, http://www.ama-assn.org/ama/pub/physician-resources/ medical-science/united-states-adopted-names-council/how-to-apply-for-usan.page? (last visited: 2013.12.02).

He, John, Drug in Focus: Docetaxel, http://www.genericsweb.com/

index.php?object_id=921 (last visited: 2013.12.14).

Milford, Phil, Sanofi-Aventis Faces Hospira, Apotex in Patent Trial (Up-date1), BLOOMBERG, Oct. 26, 2009, http://www.bloomberg.com/apps/

news?pid=newsarchive&sid=aHzAeMtX92EY (last visited: 2015.05.14).

PRANK, LINDA CHRISTINA, MODULATION OF DOCETAXEL TREATMENT

(1997), http://repub.eur.nl/pub/20361/971127_PRONK,%20Linda%20 Christina.pdf (last visited: 2015.05.14).

Reed, Brad, Google’s Latest ‘Moonshot’ May Be a Flying Car, http://bgr.com/2013/11/20/google-flying-car-rumor/ (last visited: 2013.

11.30).

SciFinder database, https://origin-scifinder.cas.org/scifinder/login (sub-scription required) (last visited: 2013.12.02).

WHO, Lists of Recommended and Proposed INNs, http://www.who.int/

medicines/publications/druginformation/innlists/en/index.html (last vis-ited: 2013.11.30).

 WHO, Procedure for the Selection of Recommended International Non-proprietary Names for Pharmaceutical Substances, http://apps.who.int/

medicinedocs/en/d/Jwhozip20b/1.html (last visited: 2013.11.30).

WORLD HEALTH ORGANIZATION,GUIDELINES ON THE USE OF I NTERNA-TIONAL NONPROPRIETARY NAMES (INNS) FOR PHARMACEUTICAL S UB-STANCES (1997), http://apps.who.int/medicinedocs/pdf/h1806e/h1806e.pdf (last visited: 2015.05.14).

TRIPS-Agreement-Based

相關文件